| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |